229 related articles for article (PubMed ID: 18245072)
1. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex.
de Boer HD; Driessen JJ; van Egmond J; Booij LH
Can J Anaesth; 2008 Feb; 55(2):124-5; author reply 125-6. PubMed ID: 18245072
[No Abstract] [Full Text] [Related]
2. Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia.
Donati F
Expert Opin Pharmacother; 2008 Jun; 9(8):1375-86. PubMed ID: 18473711
[TBL] [Abstract][Full Text] [Related]
3. A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal.
Iwasaki H; Sasakawa T; Takahoko K; Takagi S; Nakatsuka H; Suzuki T; Iwasaki H
J Anesth; 2016 Jun; 30(3):534-7. PubMed ID: 26951159
[TBL] [Abstract][Full Text] [Related]
4. First human exposure to Org 25969.
Nigrovic V; Bhatt SB; Amann A
Anesthesiology; 2006 Aug; 105(2):427; author reply 427. PubMed ID: 16871080
[No Abstract] [Full Text] [Related]
5. Sugammadex-rocuronium dosing.
Kopman AF
Anesth Analg; 2007 Sep; 105(3):883-4; author reply 884. PubMed ID: 17717263
[No Abstract] [Full Text] [Related]
6. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
[TBL] [Abstract][Full Text] [Related]
7. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
[TBL] [Abstract][Full Text] [Related]
8. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
Sorgenfrei IF; Norrild K; Larsen PB; Stensballe J; Ostergaard D; Prins ME; Viby-Mogensen J
Anesthesiology; 2006 Apr; 104(4):667-74. PubMed ID: 16571960
[TBL] [Abstract][Full Text] [Related]
9. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
10. A case where rocuronium was unable to achieve neuromuscular block immediately after sugammadex administration.
Sakai Y; Tsutsumi YM; Wakamatsu N; Soga T; Tanaka K; Oshita S
J Med Invest; 2011 Feb; 58(1-2):163-5. PubMed ID: 21372503
[TBL] [Abstract][Full Text] [Related]
11. A new approach to anesthesia management in myasthenia gravis: reversal of neuromuscular blockade by sugammadex.
de Boer HD; van Egmond J; Driessen JJ; Booij LH
Rev Esp Anestesiol Reanim; 2010 Mar; 57(3):181-4. PubMed ID: 20422852
[TBL] [Abstract][Full Text] [Related]
12. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y
Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T
Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333
[TBL] [Abstract][Full Text] [Related]
15. Rocuronium and sugammadex in myotonic dystrophy.
Baumgartner P
Anaesth Intensive Care; 2010 Sep; 38(5):959-60. PubMed ID: 20865895
[No Abstract] [Full Text] [Related]
16. The concept behind sugammadex.
Epemolu O; Bom A
Rev Esp Anestesiol Reanim; 2014 May; 61(5):272-6. PubMed ID: 24636599
[TBL] [Abstract][Full Text] [Related]
17. A novel approach to reversal of neuromuscular blockade.
Della Rocca G; Pompei L
Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic-pharmacodynamic analysis for sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade.
Kleijn HJ; Zollinger DP; van den Heuvel MW; Kerbusch T
Br J Clin Pharmacol; 2011 Sep; 72(3):415-33. PubMed ID: 21535448
[TBL] [Abstract][Full Text] [Related]
19. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.
Cammu G; de Kam PJ; De Graeve K; van den Heuvel M; Suy K; Morias K; Foubert L; Grobara P; Peeters P
Br J Anaesth; 2010 Oct; 105(4):487-92. PubMed ID: 20630888
[TBL] [Abstract][Full Text] [Related]
20. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Anesthesiology; 2006 Apr; 104(4):718-23. PubMed ID: 16571967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
